NASDAQ data is at least 15 minutes delayed.This site is protected by reCAPTCHA and the Google Our dashboard forecasting What if you’re looking for a more balanced portfolio instead?
The distribution is payable on October 16, 2020 to the stockholders of record at the close of business on September 28, 2020. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate.
American Tower today announced that its board of directors has declared its quarterly cash distribution of $1.14 per share on shares of the Company's common stock.
Similarly, looking at the bottom line, Bristol Myers Squibb adjusted earnings grew a strong 66% compared to 29% for Johnson & Johnson and 37% for Merck.
The cash dividend will be payable on October 13, 2020, to shareholders of record as of the close of business on September 25, 2020. Bristol Myers Squibb today announced that its Board of Directors has declared a quarterly dividend of forty-five cents per share on the $.10 par value common stock of the company. The site is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.Opinions expressed by Forbes Contributors are their own. Bristol-Myers Squibb Company (NYSE:BMY) has a beta value of 0.7 and has seen 1,491,914 shares traded in the recent trading session. The board of directors of AbbVie today declared a quarterly cash dividend of $1.18 per share. This industry currently has a Zacks Industry Rank of 184, which puts it in the bottom 28% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. These recent revisions tend to reflect the evolving nature of short-term business trends. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images) Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. The cash dividend is payable November 16, 2020 to stockholders of record at the close of business on October 15, 2020. Nothing contained herein shall constitute a solicitation, recommendation or endorsement to buy or sell any security. This has lagged the Medical sector's loss of 1.62% and the S&P 500's gain of 5.06% in that time.Wall Street will be looking for positivity from BMY as it approaches its next earnings report date. Leave a comment to automatically be entered into
On that day, BMY is projected to report earnings of $1.49 per share, which would represent year-over-year growth of 27.35%.
The Board of Directors of Colgate-Palmolive today declared a quarterly cash dividend of $0.44 per common share, payable on November 16, 2020, to shareholders of record on October 23, 2020. On Wednesday, Shares of Bristol-Myers Squibb Co (NYSE:BMY), lost -0.56% to $61.74.. Bristol-Myers Squibb Company, will declare results for the third quarter of 2015 on Tuesday, October 27, 2015. CHINA - 2020/08/15: In this photo illustration the American pharmaceutical company Bristol-Myers No, not quite. Bristol's most recently declared quarterly dividend was $0.45, paid August 3rd. Keytruda has established a dominant position in lung cancer, the largest oncology drugs market, and it will be difficult for Opdivo to challenge it.
The platform uses extensive data to show in a single snapshot what drives the value of a company's business.
Bristol Myers Squibb (BMY) Stock Moves -1.34%: What You Should Know Bristol Myers Squibb (BMY) closed at $58.29 in the latest trading session, marking a -1.34% move from the prior day. Bristol Myers Squibb’s revenues grew 35% between 2016 and 2019, compared to 14% growth for Johnson & Johnson and 18% for Merck.
The company, currently valued at $135.17 Billion, closed the recent trade at $59.87 per share which meant it … The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security.